| Product |
Manufacturer |
Location of Clinical Use |
FDA Approval Status |
Current Status |
| Flusol-DA-20 |
Green Cross Corporation (Osaka, Japan) |
Japan
United States |
Yes in 1989 |
Discontinued due to side effects with limited success |
| Oxygent |
Alliance Pharmaceutical Corporation (San Diego, CA) |
Europe
China
United States |
Not approved; reached phase II trials |
Discontinued due to costs |
| Oxycyte |
Synthetic Blood International (Costa Mesa, CA) |
United States |
Not approved; reached phase IIB trials |
Discontinued due to lack of enrollment into phase II trials |
| Perftoran |
Russian Academy of Sciences (Puschino, Russia) |
Russia
Mexico |
Not approved |
Rebranded as Vidaphor (Fluor02 Therapeutics, Inc., Boca Raton, FL) in the United States and currently awaiting clinical trials |
